2017 MDS ANNUAL MEETING
Thursday, March 2, 2017
Orlando, Florida
INTRODUCTION AND WELCOME
Daniela Kroshinsky, MD, MPH
Massachusetts General Hospital, Harvard Medical School
Medical Dermatology Society President
ABSTRACT PRESENTATIONS
Sweet syndrome: A retrospective clinical and histopathological analysis of 83 patients
from a tertiary academic referral center
Caroline Nelson, MD, University of Pennsylvania
Potential items for inclusion as classification criteria for discoid Lupus erythematosus (DLE):
Results of a consensus exercise
Joseph Merola, MD, MMSc, Brigham and Women’s Hospital, Harvard Medical School
Evaluation of emergency department utilization for dermatological conditions in the United States from 2010-2013
Daniel Bach, MD, MPH, Harvard Combined Dermatology Program
Gabapentin and pregabalin for the treatment of cutaneous lymphoma associated pruritus
Auris Huen, MD, PharmD, University of Texas MD Anderson Cancer Center
COMPLEX MEDICAL DERMATOLOGY CASES WITH TREATMENT CONUNDRUMS:
EXPERT PANEL AND PARTICIPANT DISCUSSION
Jeffrey Callen, MD, University of Louisville School of Medicine
Alisa N. Femia, MD, New York University, Langone Medical Center
Lindy Fox, MD, University of California, San Francisco
KEYNOTE PRESENTATION:
NOVEL THERAPEUTIC AGENTS FOR CUTANEOUS MALIGNANCIES AND ADVERSE REACTIONS
Jennifer N. Choi, MD, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center
EMERGING INFECTIOUS DISEASES TO REMEMBER IN HOSPITALIZED PATIENTS
Systematic Approach to the Differential Diagnosis
Robert Micheletti, MD, Perelman School of Medicine, University of Pennsylvania
Practical Interactive Case Examples Using Systematic Approach
Karolyn Wanat, MD, University of Iowa Carver College of Medicine
Shining Pearls: Important Lessons from Great Cases Abstract Submissions:
Pityriasis rubra-like erythroderma secondary to phosphoinositide 3-kinase inhibition
Victor Huang, MD, Brigham and Women’s Hospital, Harvard Medical School
A case of near-fatal drug rash with eosinophilia and systemic symptoms (DRESS) successfully treated with the janus kinase inhibitor tofacitinib: Is DRESS a self-limited form of hypereosinophilic syndrome?
Brett A. King, MD, PhD, Yale University
A case-based discussion of anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis
Drew Kurtzman, MD, University of Arizona
Chronic malignant acanthosis nigricans
Lauren Becker, MD, University of Minnesota
2017 LIFETIME ACHIEVEMENT AWARD
Presented by: Stephen I. Katz, MD, PhD, NIH, NIAMS
Awarded to: RUSSELL P. HALL, MD, Duke University School of Medicine
Note: Only approved presentations have been posted by the respective author(s) or presenters